Bajaj Healthcare Ltd.
NSE: BAJAJHCARE | BSE: 539872
₹299.20
₹-4.60
(-1.51%)
As on 15-Jun-2026IST
Market cap
₹1,007 Cr
Revenue (TTM)
₹611 Cr
P/E Ratio
47.2
P/B Ratio
1.9
Div. Yield
0.5 %
Quality Score
1/10
Growth Score
6/10
Valuation Score
5/10
Momentum Score
1/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹16 Cr
-
ROE
11.8 %
-
ROCE
11.4 %
-
Industry P/E
51.18
-
EV/EBITDA
10.7
-
Debt to Equity
0.1
-
Book Value
₹158.3
-
EPS
₹18
-
Face value
5
-
Shares outstanding
33,662,661
10 Years Aggregate
CFO
₹245.58 Cr
EBITDA
₹716.94 Cr
Net Profit
₹319.39 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bajaj Healthcare
| -27.9 | 1.9 | 5.4 | -42.0 | 2.2 | -- | -- |
|
BSE Healthcare*
| 8.6 | -0.1 | 10.2 | 7.2 | 23.7 | 13.2 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Bajaj Healthcare
| -34.3 | 52.2 | -15.4 | 7.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bajaj Healthcare
|
299.2 | 1,006.7 | 611.0 | 15.8 | 12.6 | 11.3 | 47.2 | 1.9 |
| 1,051.2 | 12,906.7 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.9 | 3.9 | |
| 504.3 | 8,749.6 | 947.3 | 247.8 | 28.5 | 18.9 | 35.3 | 6.4 | |
| 1,380.2 | 14,448.0 | 1,054.9 | 256.3 | 27.8 | 13.7 | 55.4 | 7.2 | |
| 1,705.6 | 32,327.5 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35 | 6.5 | |
| 385.1 | 4,197.3 | 165.8 | 46.7 | 37.8 | 16.9 | 89.9 | 14.6 | |
| 17,056.0 | 21,873.6 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.1 | 11.7 | |
| 960.9 | 4,872.1 | 811.3 | 21.0 | 0.7 | 2.1 | 237.1 | 3.8 | |
| 1,283.2 | 5,904.3 | 649.5 | 121.6 | 23.7 | 13.2 | 51.2 | 6.3 | |
| 269.9 | 7,112.5 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Bajaj Healthcare
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in... India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 " amino " 1 " adamantanol, N " boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India. Read more
-
Incorporated
1993
-
Chairman
Sajankumar Rameshwarlal Bajaj
-
Managing Director
Sajankumar Rameshwarlal Bajaj
-
Headquarters
Thane Dist, Maharashtra
-
Website
Looking for more details about Bajaj Healthcare Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCompliances-Statement Of Deviation & Variation
08-May-2026Results- Financial Results For 31/03/2026
08-May-2026No News & Announcements are available.
FAQs for Bajaj Healthcare
What is the current share price of Bajaj Healthcare Ltd Today?
The share price of Bajaj Healthcare Ltd is ₹299.20 (NSE) and ₹299.05 (BSE) as of 15-Jun-2026 IST. Bajaj Healthcare Ltd has given a return of 2.16% in the last 3 years.
What is the current PB & PE ratio of Bajaj Healthcare Ltd?
The P/E ratio of Bajaj Healthcare Ltd is 47.24 times as on 15-Jun-2026, a 8 discount to its peers’ median range of 51.18 times.
The P/B ratio of Bajaj Healthcare Ltd is 1.89 times as on 15-Jun-2026, a 50 discount to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
49.42
|
4.73
|
|
2024
|
0.00
|
2.90
|
|
2023
|
13.24
|
2.29
|
|
2022
|
13.16
|
2.86
|
|
2021
|
3.92
|
2.52
|
What is the 52 Week High and Low of Bajaj Healthcare Ltd?
The 52-week high and low of Bajaj Healthcare Ltd are Rs 552.60 and Rs 272.35 as of 16-Jun-2026.
What is the market cap of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has a market capitalisation of ₹ 1,007 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bajaj Healthcare Ltd?
Before investing in Bajaj Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.